ConductScience.org, home

Paper41568342

S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase.

Rosas-Lemus M and 18 others. ACS Med Chem Lett, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase. Papers, record 41568342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41568342

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase.
PubMed
Journal
ACS Med Chem Lett
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-20
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosas-Lemus MMonica
2Athe SSudhakar
3Minasov GGeorge
4Pattie JAJason A
5Brunzelle JSJoseph Shttps://orcid.org/0000-0001-9197-0018
6Chau IIrene
7Li FFengling
8Vedadi MMasoud
9Ma HHeng
10Ramanathan AArvindhttps://orcid.org/0000-0002-1622-5488
11Becker MEMark E
12Hope TJThomas J
13Abdelkarim HHazem
14Grudzien PPatrick
15Gaponenko VVadim
16Montgomery JEJeffrey E
17Moellering RERaymond Ehttps://orcid.org/0000-0002-2043-7838
18Rawal VHViresh Hhttps://orcid.org/0000-0003-4606-0239
19Satchell KJFKarla J Fhttps://orcid.org/0000-0003-3274-7611

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
75N93022C00035NIAID NIH HHSUnited StatesPubMedPubMed
U01 AI124316NIAID NIH HHSUnited StatesU01AI124316PubMedNIH RePORTER
P20 GM121176NIGMS NIH HHSUnited StatesP20GM121176PubMedNIH RePORTER
75N93022C00035NIH HHSUnited StatesPubMedPubMed
HHSN272201700060CNIAID NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137294077Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase.J Med Chem2023https://conductscience.org/library/papers/37294077PubMed
226041293Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived Peptide In Vitro and In Vivo To Reduce Replication and Pathogenesis.J Virol2015https://conductscience.org/library/papers/26041293PubMed
336770656Coronavirus Inhibitors Targeting nsp16.Molecules2023https://conductscience.org/library/papers/36770656PubMed
434257831Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate.ACS Med Chem Lett2021https://conductscience.org/library/papers/34257831PubMed
538718835Accurate structure prediction of biomolecular interactions with AlphaFold 3.Nature2024https://conductscience.org/library/papers/38718835PubMed
636285486Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction.EMBO Rep2022https://conductscience.org/library/papers/36285486PubMed
741502823Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase.RSC Med Chem2026https://conductscience.org/library/papers/41502823PubMed
829133831Protein-Ligand Blind Docking Using QuickVina-W With Inter-Process Spatio-Temporal Integration.Sci Rep2017https://conductscience.org/library/papers/29133831PubMed
937728236Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors.ACS Infect Dis2023https://conductscience.org/library/papers/37728236PubMed
1037546609Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors.ACS Omega2023https://conductscience.org/library/papers/37546609PubMed
1135439007Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues.J Med Chem2022https://conductscience.org/library/papers/35439007PubMed
1234131072Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.Sci Signal2021https://conductscience.org/library/papers/34131072PubMed
1336546776Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development.Nucleic Acids Res2023https://conductscience.org/library/papers/36546776PubMed
1436722972SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.J Virol2023https://conductscience.org/library/papers/36722972PubMed
1539869355Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus.JAMA Intern Med2025https://conductscience.org/library/papers/39869355PubMed
1634315512N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.J Hematol Oncol2021https://conductscience.org/library/papers/34315512PubMed
1736075969High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development.Nat Struct Mol Biol2022https://conductscience.org/library/papers/36075969PubMed
1817845853The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi.Bioorg Med Chem2007https://conductscience.org/library/papers/17845853PubMed
1934192965Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.SLAS Discov2021https://conductscience.org/library/papers/34192965PubMed
2034101213SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.EMBO J2021https://conductscience.org/library/papers/34101213PubMed

See all 38 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41568342

GET https://conductscience.org/api/papers/v1/41568342/references?page=2